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esponsibility of InstAbstract In China, over 40 species of the genus Salvia have been used as medicinal plants for various diseases,
some for thousands of years. Recently, research has focused on the biological activities of Salvia medicinal plants
used in traditional chinese medicine (TCM). However, to date a scientiﬁc survey of the genus Salvia in China has
not been carried out. In this paper, we report the results of 10 ﬁeld surveys of Salvia medicinal plants collected in
17 provinces including detailed information on their local names, growing environment, distribution and
therapeutic effects. We also summarize the results of research on the materia medica, phytochemistry and
pharmacology of some of the important Salviamedicinal plants. Our study reveals that 35 Salvia plants have been
used in TCM in different regions of China, including 20 species used as Danshen to treat heart diseases, and
15 species used to treat a range of other conditions including gynecological diseases, muscular or skeletal
problems, hepatitis, urological diseases, and mouth and eye conditions. It is clear that some species of Salvia L.
possess signiﬁcant pharmacological activity in the context of ethnopharmacological knowledge, especially in the
treatment of heart disease. Further studies of the phytochemistry and pharmacology of Salvia species will no
doubt improve their medical utilization and contribute to the development of new natural drugs.
& 2013 Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical
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M. Li et al.2741. Introduction
Salvia L. species constitute the largest genus in the family
Lamiaceae with over 1000 species distributed mainly in Central
and South America (500 spp.), Central Asia/Mediterranean
(250 spp.) and Eastern Asia (100 spp.). Most species are perennial
herbs but annuals, shrubs and a few trees and vines also exist1. 84
Salvia species are native to China with their distribution located in
South-West China, notably in the Hengduan Mountain region2.
Salvia species have been used in herbal medicine for thousands
of years. In fact, the name Salvia comes from the Latin word
“salvare” meaning “to heal” and S. ofﬁcinalis (Sage) has long been
an important herb in Europe. Salvia species have been used in the
treatment of more than sixty different ailments ranging from aches
and pains to epilepsy although their main application has been in
treating colds, bronchitis, tuberculosis, hemorrhage and menstrual
disorders3. Until the discovery of antibiotics, Sage was a frequent
ingredient of herbal teas recommended to patients with tubercu-
losis to prevent sudation. The leaves of Sage exhibit a range of
biological activities based on their astringency and antibacterial,
micostatic, virustatic and antihidrotic properties and are included
in the British Herbal Pharmacopoeia (1983) for use as a gargle or
mouthwash. Sage has also been included in combined herbal
preparations for treating acute and chronic bronchitis4.
In China, over 40 species of Salvia have been used as medicinal
plants for various diseases, some for thousands of years. One of the
most well-known herbs is the roots of S. miltiorrhiza Bunge (Red
Sage, called Danshen in Chinese) which is endemic to Eastern Asia,
and is included as an ofﬁcial drug in the Chinese Pharmacopeia
(2010). Traditionally Danshen has been used to promote blood
circulation, remove stagnation, tranquilize the mind, clear heat from
the blood and resolve swelling5. In more recent times, the most
important and frequent clinical use of Danshen has been in the
treatment of coronary heart disease for the alleviation of angina
pectoris, coronary artery spasm and myocardial infarction6,7.
Although there is increasing interest in the biological activity of
Salvia species8,9, to date a scientiﬁc survey of the genus Salvia in
China has not been reported. Given that the indigenous uses of many
Salvia medicinal plants remain undocumented, we undertook the
survey to collect information relating to the resource and use of Salvia
plants in Traditional Chinese Medicine (TCM) in order to provide
baseline data for future pharmacological and phytochemical studies.2. Materials and methods
During the period 2006–2011, we conducted 10 ﬁeld surveys in 17
provinces and regions of China (Beijing, Hebei, Henan, Shandong,
Anhui, Jiangsu, Zhejiang, Hubei, Hunan, Jiangxi, Fujian, Shanxi,
Gansu, Chongqing, Sichuan, Guangxi and Yunnan provinces)
based on analysis of ancient medicinal works and local knowledge
of herbal medicines that include Salvia species. With the assistance
of local herbalists, we collected plant samples and recorded
detailed information on their local names, growing environment,
distribution and therapeutic effects (Table 1). Voucher specimens
of each plant species were identiﬁed by professional experts and
their scientiﬁc names conﬁrmed by consulting the Flora of China2.
The specimens were pressed and deposited at the Pharmaphylo-
geny Laboratory of the Institute of Medicinal Plant Development,
Chinese academy of Medical Sciences, and the Molecular Phar-
macognosy Laboratory of the Institute of Chinese Materia Medica,
China Academy of Traditional Chinese Medicine.3. Results and discussion
In the Flora of China, Chinese Salvia species are classiﬁed into four
subgenera namely Salvia, Sclarea, Jungia and Allagospadonopsis10.
Table 1 lists the species identiﬁed in this study arranged according to
this classiﬁcation system together with their local names, collection
location, growing environment and therapeutic use.
3.1. Ethnopharmacological investigation
According to our ﬁeld survey, 35 Salvia plants have been used as
folk medicine in multiple therapeutic remedies in different regions
of China. All four subgenera are represented with Sclarea (15)
being the dominant subgenus, followed by Salvia (12), Allagos-
padonopsis (6) and Jungia (2).
Of the 35 Salvia species identiﬁed, 20 are used as Danshen to treat
heart disease, 7 are used to treat respiratory diseases (cough,
pneumonia and tracheitis), 8 for gynecological diseases (mastitis,
dysmenorrheal and irregular menstruation), 2 for muscular or skeletal
problems (muscular twitching pain and rheumatic arthritis), 3 for
hepatitis, 2 for urological diseases (nephritis and urethritis), 2 for
mouth and eye conditions (keratitis, faucitis and toothache), and 5 for
other conditions (snakebite, sexual dysfunction, fever, hypertension
and pyogenic infection of the skin) (Fig. 1A).
Parts of Salvia species used in the preparation of herbal
remedies were the roots (20 species), herbs (14 species), leaves
(2 species), ﬂowers (2 species), seeds (1 species) and fruits
(1 species) (Fig. 1B). It is well known that different parts of
plants contain different concentrations of active constituents and
different phytochemicals11. For example, ﬂavonoids, triterpenoids
and monoterpenes are found in the aerial parts of Salvia plants
particularly the ﬂowers and leaves, whereas diterpenoids and
phenolic acids are mainly found in the roots3. In our survey, it
emerged that, generally, only one part of a medicinal plant is used
in the preparation of a particular herbal remedy. For example, the
herbs of S. roborowskii are used to treat hepatitis, while its ﬂowers
are employed to treat toothache. Sometimes Salvia plants have
been used as the sole ingredient in a herbal medicine but often they
are used in combination with more than one medicinal plant. For
example, the leaves of S. ofﬁcinalis are used in a tea to prevent and
treat hypertension whereas the roots of S. miltiorrhiza and its
related species are used in combination with other herbal
medicines (Rhizoma ligustici wallichii, Radix astragalus, Radix
notoginseng) for the management of heart disease.
Decoctions or infusions are most commonly used for oral
administration and only one species, S. cavaleriei, has been
prepared for external use involving topical application of its
crushed leaves to the site of pyogenic infection.
3.2. Details of some widely used Chinese Salvia species
According to our ﬁeld survey, ethnopharmacological knowledge
of Chinese Salvia species is indicative of their pharmacological
activity especially in the treatment of heart disease and cancer.
Based on the limited research into their phytochemistry and
pharmacology, only those Salvia species of signiﬁcant medicinal
value are described below.
3.2.1. S. miltiorrhiza and related species
S. miltiorrhiza is designated as the ofﬁcial source of Danshen in
the Chinese Pharmacopeia (2010). The earliest record of Danshen
Table 1 Names, distribution and therapeutic use of Salvia medicinal plants in China.
Original plant (voucher number) Local name Collecting location and time Growing environment Used part and therapeutic effects
Subg. Salvia Benth.
Sect. Eurysphace Stib.
S. bulleyana Diels HLQ-SBU-
1101-1
Zi Danshen Dali, Yunnan Aug 2011 Hillsides, valleys (Alt. 2500–3100 m) The roots were used as Danshen.
S. brachyloma Stib HLQ-SBR-
1001-8
Duan Guan
Danshen
Muli, Sichuan Aug 2010 Hillsides, valleys (Alt. 3000–3300 m) 1. The roots were used as Danshen.
2. The ﬂowers could be used to treat cough.
S. campanulata Wall.
2006070808
Huang Hua
Danshen
Deqin, Yunnan Jul 2006 Forests, hillsides, grasslands (Alt.
2800–3500 m)
The roots were used as Danshen
S. castanea Diels 2006070803 Rong Mao
Danshen
Muli, Sichuan Jul 2006 Forests, hillsides, grasslands (Alt.
2500–3200 m)
The roots were used as Danshen.
S. digitaloides Diels HLQ-SDI-
1001-1
Yin Zi Danshen,
Bai Yuan Shen
Lijiang, Yunnan Aug 2010 Dry shady pine forests, grassy
hillsides, valleys (Alt. 2200–2800 m)
The roots were used as Danshen.
S. evansiana Hand.-Mazz.
2006090805
Danshen Xianggelila, Yunnan Sep 2006 Alpine meadows, hillsides, forests
(Alt. 3400–4150 m)
The roots were used as Danshen.
S. ﬂava Forrest. HLQ-SFL-
1001-8
Huang Hua
Danshen
Lijiang, Yunnan Jul 2010 Forests, hillsides, grasslands (Alt.
2300–3500 m)
The roots were used as Danshen.
S. kiaometiensis Lévl. HLQ-
SQM-1001-7
Shan Bian,
Danshen
Zhaotong, Yunnan Jul 2010 Hillsides (Alt. 2200-2800 m) The roots were used as Danshen.
S. przewalskii Maxim. HLQ-
SPZ-1101-8
Zi Danshen,
Hong Qinjiao
Xianggelila, Yunnan Jul 2011 Forest margins, hillsides, banks of
streams, thickets (Alt. 2000–3500 m)
1. The roots were used as Danshen.
2. The roots were used as Qinjiao which has the effects of expelling wind,
dredging, removing the heat from the blood and relieving swelling.
S. roborowskii Maxim. HLQ-
SRO-1001-5
Ye Zhi Ma Kangding, Yunnan Jul 2010 Hillsides (Alt. 2600–3500 m) 1. The ﬂowers could be used to treat toothache.
2. The herbs could be used to treat hepatitis.
3. The fruits could be used to treat keratitis.
S. umbratica Hance HLQ-SUM-
1001-7
Shan Su Zi Ningqiang, Shanxi Aug 2010 Hillsides, banks of streams, forests,
valleys (Alt. 600–1500 m)
The herbs and seeds could be used to treat irregular menstruation.
Sect.Eusphace Benth.
S. ofﬁcinalis L. HLQ-SOF-
1001-4
Sai Er Wei Ya Beijing Aug 2010 Cultivated in gardens The leaves could be used to treat faucitis and hypertension.
Subg. Sclare (Moench) Benth.
Sect. Drymosphace Benth.
S. bowleyana Dunn
2007081601
Danshen, Zi Gen Jinhua, Zhejiang Aug 2007 Hillsides, banks of streams, valleys
(Alt. 300–800 m)
The roots were used as Danshen.
S. cavaleriei Lévl HLQ-SCA-
1001-2
Xue Pen Cao Emeishan, Sichuan Jul 2011 Hillsides, banks of streams, forests,
valleys (Alt. 300–1500 m)
1. The herbs were used to treat irregular menstruation.
2. The leaves could be used to treat pyogenic infection of the skin.
S. dabieshanensis J.Q.He
2007062004
Danshen, Hong
Gen
Shucheng, Anhui Jun 2007 Hillsides, margins of thicket (Alt.
600–1000 m)
The roots were used as Danshen.
S. honania L.H.Bailey
2007061503
Danshen Xinyang, Henan Jun 2007 Hillsides (Alt. 600–900 m) The roots were used as Danshen.
S. meiliensis S.W.Su
2007062101
Hong Gen,
Danshen
Liuan, Anhui Jun 2007 Hillsides, roadsides (Alt. 800–
1100 m)
The roots were used as Danshen.
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Table 1 (continued )
Original plant (voucher number) Local name Collecting location and time Growing environment Used part and therapeutic effects
S. miltiorrhiza Bunge HLQ-
SMI-1101-05
Hong Gen,
Danshen,
Jiangxian, Shanxi Jun 2011 Hillsides, banks of streams, plains,
forests (Alt. 0–1100 m)
The roots were used as Danshen.
S. paramiltiorrhiza H.W. Li et
X.L.Huang HLQ-SPA-1001-01
Danshen, Hong
Gen
Qingtian, Anhui Jun 2010 Hillsides, banks of streams (Alt.
350–900 m)
The roots were used as Danshen.
S. plectranthoides Griff. HLQ-
SPL-1001 -07
Hongshen, Jin
Zhi Danshen
Wudu, Gansu Jun 2010 Hillsides, banks of streams, valleys,
sparse forests (Alt. 800–2200 m)
1. The roots were used as Danshen.
2. The roots were used for treatment of arthralgia due to dampness,
muscular twitching pain and hemiplegia.
3. The roots were used to treat cough.
S. prionitis Hance HLQ-SPR-
100001-07
Hong Gen Cao Jinhua, Zhejiang Sept 2010 Hillsides, banks of streams (Alt.
150–800 m)
The herbs were used to treat cough, antiaditis tracheitis, diarrhea, hepatitis
and cancer.
S. sinica Migo 2006070401 Danshen Jinzhai, Anhui Jul 2006 Hillsides, banks of streams (Alt.
350–800 m)
The roots were used as Danshen.
S. trijuga Diels. HLQ-STR-
1001-03
Xiao Hongshen,
Zi Danshen
Lijiang, Yunnan Aug 2010 Foothills, riverbanks, banks of
streams, grasslands (Alt.
2100–3500 m)
1. The roots were used as Danshen.
2. The roots could be used to treat deﬁciency in kidney and deﬁciency
of yang.
S. vasta H.W. Li 2007062103 Danshen Enshi, Hubei Jun 2007 Hillsides (Alt. 800–1000 m) The roots were used as Danshen.
S. yunnaensis C.H.Wright.
2006092002
Dian Danshen,
Yunnan Danshen
Kunming, Yunnan Sep 2006 Grassy hillsides, dry thin forests
(Alt. 2000–3300 m)
1. The roots were used as Danshen.
2. The roots could treat mastitis.
Sect. Plethiosphace Benth.
S. deserta Schang HLQ-SDE-
1001-3
Xinjiang Shu
Wei Cao
Buerjin, Xinjiang Aug 2010 Foothills, hillsides, grasslands
(Alt. 300–1500 m)
The herbs were used to treat cough and urethritis.
Sect. Notiosphace Benth.
S. plebeia R.Br. HLQ-SLZ-
1001-1
Li Zhi Cao Jinhua, Zhejiang Sep 2010 Foothills, hillsides, riverbanks,
grasslands (Alt. 100–2500 m)
The herbs were used to treat faucitis, bronchitis, nephritis and urethritis.
Subg. Jungia (Moench) Briq.
Sect. Calosphace Benth.
S.splendens Ker-Gawl.
2006081702
Yi Chuan Hong Beijing Aug 2006 Cultivated in gardens The herbs were used to treat fever.
S. coccinea Linn HLQ-SZC-
1001-2
Zhu Chun Beijing; Aug 2011 Cultivated in gardens The herbs were used to treat snakebite.
Subg. Allagospadonopsis Briq.
S. chinensis Benth. HLQ-SXC-
1002-10
Shi Jian Chuan Chuzhou, Anhui Aug 2010 Foothills, hillsides, riverbanks,
grasslands (Alt. 100–500 m)
The herbs were used to treat hepatitis, dysmenorrhea and acute mastitis.
S. japonica Thunb. 2007070802 Ba Wang Bian,
Qiu Danshen
Badong, Hunan Aug 2007 Foothills, riverbanks, banks of
streams, grasslands (Alt. 400–1000 m)
The herbs were used to to clear heat from blood, treat hepatitis,
dysmenorrhea, acute mastitis and irregular menstruation.
S. kiangsiensis C.Y.Wu HLQ-
SKI-1001-08
Guan Gong Xu,
Gen Xia Hong
Nanfeng, Jiangxi Aug 2011 Forests; (Alt. 600–800 m) The herbs were used to clear heat from blood, treat acute mastitis and
irregular menstruation.
S. liguliloba Sun HLQ-SSB-
1001-03
Chang Ye,
Danshen
LinAn, Zhejiang Aug 2010 Foothills, riverbanks, banks of
streams, grasslands; (Alt. 600–800 m)
The herbs were used to clear heat from blood, treat rheumatoid arthritis and
irregular menstruation.
S. substolonifera Stib. HLQ-
SSU-1001-5
Fo Guang Cao LinAn, Zhejiang Aug 2010 Foothills, banks of streams,
grasslands; (Alt.300–800 m)
The herbs were used to clear heat from blood and treat cough and
pneumonia.
S. scapiformis Hance HLQ-
SDG-1001-8
Po Luo Zi, Bai
Bu Yao
Leshan, Sichuan Aug 2010 Foothills, banks of streams,
grasslands; (Alt. 900–1100 m)
The herbs were used to clear heat from blood, treat cough and pneumonia.
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Figure 1 (A) The proportion of Salvia plants used to treat different diseases and (B) the proportion of the parts of Salvia plants used in their
preparation.
Figure 2 Images of some species of Salvia recorded in the Yunnan Materia Medica12 and An Illustrated Book of Plants13.
An ethnopharmacological investigation of medicinal Salvia plants (Lamiaceae) in China 277appears to be from the Eastern Han Dynasty (Shen Nong Materia
Medica, A.D. 102–200). Later, it was recorded in many other well-
known medicinal texts, e.g., Tang Materia Medica (Tang Dynasty,
A.D. 657–659), Classic Classiﬁed Materia Medica for Emergen-
cies (Song Dynasty, A.D. 1082), Compendium of Materia Medica
(Ming Dynasty, A.D. 1590) and Illustrated Book of Plants (Qing
Dynasty, A.D. 1848), etc. In the ancient texts, the curative
properties of Danshen were to promote blood circulation, remove
stagnation, tranquilize the mind, clear heat from the blood and
resolve swelling. In terms of morphology, the original species
were described as roots red or purple and leaves comprising 5 or 7
leaﬂets opposited with the spica made up of purple ﬂowers. In
many ancient texts12,13, the morphological characteristics were
appropriate for many Salvia plant such as S. plectranthoides, S.
yunnanensis and S. trijuga (Fig. 2).
According to the results of our ethnopharmacological investiga-
tion, about 20 species of Salvia L. have been used as Danshen for
the treatment of coronary heart disease and stroke. Based on their
morphological characteristics and geographical distribution, these
Danshen related species are divided into 2 groups. Group 1
comprises 11 species S. bulleyana, S. brachyloma, S. campanu-
lata, S. castanea, S. digitaloides, S. evansiana, S. ﬂava,
S. kiaometiensis, S. przewalskii, S. trijuga and S. yunnaensis;
Group 2 comprises 9 species namely S. bowleyana, S. dabiesha-
nensis, S. honania, S. meiliensis, S. miltiorrhiza, S. paramiltior-
rhiza, S. plectranthoides, S. sinica and S. vasta.
Most Danshen related species (except S. trijuga and
S. yunnanensis) in Group 1 come from sect. Euryspace, and are
mainly distributed in the plateau area at 2500–4000 m above sea
level in Sichuan and Yunnan provinces of South-West China.S. przewalskii in this group has been widely used and is
commercially available in the local herbal markets of Sichuan,
Yunnan and Gansu provinces. The geographical distribution and
resources of other Danshen related species in Group 1 are limited
and their applications in folk medicine are restricted to remote
mountain areas and minority regions of Sichuan and Yunnan
provinces. In addition, some Danshen related species have been
applied for other therapeutic effects in different regions. For
example, the roots of S. przewalskii have been employed to treat
rheumatism in the West of Sichuan province and the roots of S.
trijuga have been used as a tonic in the West of Yunnan province.
All Danshen related species in Group 2 are from sect.
Drymophace, and are distributed at low altitudes in plains and
hills of North, East and Central China. S. miltiordsrhiza is widely
used in most regions of China, including some minority regions
such as Inner Mongolia, and is cultivated on a large scale in Hebei,
Henan, Shanxi, Shandong and Sichuan provinces. However, it is
not easy to distinguish from some morphologically allied species.
The farmers and villagers in rural communities generally seek to
collect roots which have the red bark of Salvia species and use
them as Danshen. As a result, in some herb markets, Danshen may
come from the roots of species other than S. miltiorrhiza,
especially in regions where several morphologically allied species
are present. For example, the roots of S. bowleyana, known as
Nandanshen, are available for purchase and use as Danshen in
remote mountain areas of Zhejiang, Jiangxi and Fujian provinces
and the roots of S. dabieshanensis and S. paramiltiorrhiza are used
as Danshen in Dabie mountain areas of Anhui and Hubei
provinces. In our previous studies, the amounts of salvianolic
acid B or tanshinone IIA in some species of Salvia met the
M. Li et al.278requirements of the Chinese Pharmacopoeia14 but further pharma-
cological and phytochemical studies in relation to the application
of these Danshen related species are needed.
To date, only a few Danshen related species such as S.
miltiorrhiza have been studied extensively. Over 50 chemical
constituents have been isolated and identiﬁed in S. miltiorrhiza,
all of which can be classiﬁed as either hydrophilic phenolic acids
such as salvianolic acid B and lithospermic acid or lipophilic
tanshinones such as tanshinones I, IIA, and IIB and cryptotanshi-
none15–17. Based on modern studies, the most important and
frequent clinical application of the roots of S. miltiorrhiza has been
in the treatment of heart conditions including angina pectoris,
coronary artery spasm and myocardial infarction6,7,18. However,
they have also been used for treating neuroasthenic insomnia,
hypertension dysmenorrhea, bone loss and chronic renal failure17,19–
22. Interestingly, the root of S. miltiorrhiza has been shown to
reduce voluntary alcohol intake in selectively bred Sardinian
alcohol-preferring rats, a ﬁnding that suggests it may have potential
in treating alcoholism18. The aqueous extract has also been shown
to inhibit HIV-1 integrase activity in vitro and viral replication
in vivo. Since salvianolic acid B and lithospermic acid are the major
biologically active constituents, the activity against HIV virus may
indicate their potential as novel therapeutic drugs for AIDS22.
Another extensively studied Salvia species is S. yunnanensis
From which some 40 compounds have been isolated and identi-
ﬁed. These include abietane diterpenes (yunnanin A, danshenol C),
phenolic acids (yunnaneic acids E–H) and alkaloids (salviamines
A–F)23–27. Based on recent pharmacological studies, the roots of S.
yunnanensis were shown to prevent scar-derived ﬁbroblast forma-
tion28 and the polyphenols and their derivatives to have potent
anti-HIV activity29,30. In addition, the roots of S. yunnanensis were
reported to be useful in treating hepatocarcinogenesis31.3.2.2. S. plebeia
S. plebeia (Lizhicao in Chinese) is another valuable medicinal
plant widely distributed in Iran and throughout South East Asia as
far as Eastern Australia. The earliest record of S. plebeia was in the
Compendium of Materia Medica (Ming Dynasty, A.D. 1590) to
treat snake bite and trauma. In the supplement to the later
compendium (Qing Dynasty, A.D. 1765) the plant was said “to
clear heat and toxic materials, and to remove heat from blood and
diuresis”. Results of our ethnopharmacological studies indicate
that S. plebia has been used to treat bleeding, perineum edema
resulting from hemorrhoids, swollen sore throat, bronchitis,
hepatitis, cancer, nephritis and mastitis. In recent decades, about
40 chemical constituents have been isolated from this species
including ﬂavonoids, phenolic acids, diterpenes, triterpenes and
others. Individual compounds in these classes include: Flavonoids
nepitrin32, 2′-hydroxyl-5′-methyoxybiochanin A33, 5-hydroxy-
4′,7-dimethoxy-isoﬂavone34, pectolinarigenin35, luteolin-7-O-β-D-
glucoside36, 6-methoxynaringenin-7-O-β-D-glucoside37 and luteo-
lin38; phenolic acids caffeic acid32, caffeic acid methyl ester35,
rosmarinic acid methyl ester36 and 3,4-dihydroxybenzoic acid39;
diterpenes epoxysalviacoccin, salviacoccon40, royleanonic acid41,
carnosol and epirosmanol35; triterpenes ursolic acid35, 2α,3β,24-
trihydroxy and 2α,3β-dihydroxyolea-12-en-28-oic acid and oleanic
acid39; and other compounds conferyl aldehyde, β-sitosterol33,
scopoletin, salviaplebeiaside35, β-daucosterol39 and two lignin
diesters42,43.
Recent pharmacological studies of S. plebeia reveal it displays a
variety of biological activities consistent with its extensive use inTCM. First, the aqueous and ethanol extracts inhibit the growth of
human gastric carcinoma cell lines, suggesting it acts as a potent
immunomodulator44. Second, the extract of S. plebeia possesses
antiangiogenic, antinociceptive, antiinﬂammatory, antifungal and
antioxidant activities33,45,46. Third, the homoplantaginin isolated
from S. plebeia was reported to be protective against hepatocyte
injury47. Finally, in combination with other herbal ingredients [the
seeds of Plantago asiatica L., the roots of Serissa serissoides
(DC.) Druce and the herbs of Viola philipica Cav. Lcons et
Descr.], this species has been used to treat urinary tract infections
and exhibit signiﬁcant diuretic, antiblastic, antipyretic, antiinﬂam-
matory and antidynous activities48.3.2.3. S. prionitis
Another Salvia species valued in folk medicine for its therapeutic
activity is S. prionitis (Honggencao in Chinese), the aerial parts of
which have been used to treat cold, cancer, pneumonia, hepatitis and
diarrhea. Previous phytochemical investigations revealed the presence
of more than 50 secondary metabolites among which abietane
diterpenes are the overwhelming majority. These include tanshinone
IIA, cryptotanshinone49, salvilenone50, 3-ketosapriparaquinone51,
4-hydroxysaprorthoquinone52,53, apriparaquinone54, de-O-ethylsalvoni-
tin55, prioketolactone56, 2-isopropyl-8-methyl-3,4-phenanthraquinone57,
hongencaotone58, 3-keto-4-hydroxysaprorthoquinone59, danshenxinkun
C60, prionoid F61, bisprioterone C62 and dihydrotanshinone I63. It was
reported that some abietane diterpenes in this plant showed signiﬁcant
antitumor activity both in vitro and in vivo. For example, saprortho-
quinone showed cytotoxicity against P-388 and L-1210 cultured cells
and a therapeutic effect against various ascites tumors in mice49,64; 3-
keto-4-hydroxysaprorthoquinone exhibited cytotoxic activities against
HL-60 human leukemia cells and the SGC-7901 and MKN-28
stomach cancer cell lines with IC50 values of 4.6, 0.2 and 0.3 μM,
respectively59, prionoid D and E also showed signiﬁcant cytotoxic
activity against P-388 and A-549 cell lines with IC50 values of 0.41 and
0.72 μM, respectively61 In addition, some diterpenes from S. prionitis
showed antimicrobial activities including 7,8-seco-para-ferruginone
against Gram-positive Staphylococcus aureus and Micrococcus luteus
(MIC values of 20.0 and 15.0 μM)59. However, a full understanding of
the biological effects of this plant requires the bioactivities of individual
compounds to be further evaluated.3.2.4. S. chinensis
S. chinensis, known as Shijianchuan (Chinese Sage) in folk
medicine, was ﬁrst recorded in the Compendium of Materia
Medica (Ming Dynasty, A.D. 1590). In this famous ancient text,
S. chinensis was recorded as a treatment for ostealgia and swollen
carbuncles. However, our ethnopharmacological investigation
revealed that this herbal medicine has been employed to treat
breast cancer, liver cancer, stomach cancer and hepatitis.
A phytochemical investigation of S. chinensis revealed over 50
chemical constituents in four classes of compounds: terpenoids
(monoterpenoids, sesquiterpenes and triperpenoids), phenolic
acids, ﬂavonoids and others. Individual members of each class
include: Terpenoids α-boswellic acid65, blumenol A, clovane-
2β,9α-diol66 and pinfaenoic acid67; phenolic acids salvianolic acid
D68, salvianolic acid B69, propanoic acid, 3-(3,4-dihydroxyphe-
nyl)-2-hydroxybenzoic acid70, 3,5-dimethoxy-4-hydroxybenzoic
acid71, 5,7,4′-trihydroxydihydroﬂavonol71 and protocatechuic
acid72; ﬂavonoids 3,5,7-trihydroxychromone and kaempferol67;
and other compounds β-sitosterol65,73, 5-hydroxymethyl furalde-
hyde73, syringaresinol71 and various aldehydes65,73.
An ethnopharmacological investigation of medicinal Salvia plants (Lamiaceae) in China 279Modern pharmacological research has revealed that the aqueous
extract of S. chinensis can signiﬁcantly inhibit the proliferation of
human nasopharynx cancer CNE cells and human gastric cancer
MGC-803 cells74. Polysaccharides isolated from S. chinensis
exhibited strong antitumor activity75,76 and were also reported to
stimulate B-lymphocytes and, at a concentration of 20 mg/L,
protect PC-12 cells against H2O2-induced injury
76–78. In addition,
S. chinensis was reported to protect against CCl4-induced acute
liver injury in mice probably due to the antioxidant activity of the
phenolic acids present in this herbal medicine79.
Again this species has not been studied extensively and little is
known about the active substances responsible for its bioactivities,
especially its anticancer activity.
3.2.5. Other species
Based on our investigations of folk medicines, six Salvia species
(S. japonica, S. kiangsiensis, S. liguliloba, S. substolonifera, S.
scapiformis and S. coccinea) have been mainly used to clear heat
from the blood. The results indicate that Salvia plants may be a
source of new drugs possessing antibacterial, antiviral and anti-
tumor activities. The leaves of S. ofﬁcinalis have been used in tea
to prevent and treat hypertension but the bioactivities of its
individual chemical constituents remain to be assessed.4. Conclusions
Despite the recorded use of 35 Salvia plants in folk medicine, only
a few species have been studied extensively and many questions
remain in relation to their systematic classiﬁcation, identiﬁcation
and resource utilization. Nevertheless, it is clear that some species
of Salvia L. possess signiﬁcant potential in the treatment of heart
disease. The diterpenoids and the caffeic acid derivatives are the
most characteristic compounds in the genus14,63, most of which are
associated with antioxidant, anticoagulant and cytoprotective
activities. They also possess a wide variety of other activities
including anti-ischemia-reperfusion injury, antihypertensive, anti-
ﬁbrotic, antiviral and antitumor activities22,32,80,81. However, many
species of Salvia remain to be explored in terms of their safety or
toxicity and their phytochemical and pharmacological character-
isticsin order to improve their medical utilization and develop
effective natural drugs.
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